Last reviewed · How we verify

NCT05111587: EPITRAUMABLOC

Epidemiology of Injuries Caused by the Practice of Artificial Structure Climbing

Completed Last updated 29 September 2023
What this trial tests

trial testing Questionnaire in Sport Injury in 266 participants. Completed in 31 December 2022.

Timeline
16 November 2021
Primary endpoint
16 February 2022
31 December 2022

Quick facts

Lead sponsorCentre Hospitalier Universitaire de la Réunion
StatusCompleted
Study typeOBSERVATIONAL
Enrollment266
Start date16 November 2021
Primary completion16 February 2022
Estimated completion31 December 2022
Sites1 location across Reunion

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire de la Réunion

Who can join

18 and older, any sex, with Sport Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to precisely describe epidemiology of injuries than occur during practice of climbing in artificial structure. Each participant will complete questionnaires in order to identify injuries. The first questionnaire will be completed at the moment of the inclusion and the second questionnaire will be completed if participant has injuries every 3 months until month 12.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Questionnaire

Trials testing the same drug.

Other recruiting trials for Sport Injury

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire de la Réunion trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05111587.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing